Daly James M is a director of Halozyme Therapeutics Inc.
Person profile
Roles
Address
Wilmington, Delaware
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
ACADIA PHARMACEUTICALS INC
31 May 24
4
MADRIGAL PHARMACEUTICALS, INC.
3 Apr 24
144
MADRIGAL PHARMACEUTICALS, INC.
1 Apr 24
4
HALOZYME THERAPEUTICS, INC.
15 Aug 23
144
HALOZYME THERAPEUTICS, INC.
14 Aug 23
144
HALOZYME THERAPEUTICS, INC.
11 Aug 23
4
MADRIGAL PHARMACEUTICALS, INC.
20 Jun 23
4
ACADIA PHARMACEUTICALS INC
5 Jun 23
4
HALOZYME THERAPEUTICS, INC.
9 May 23
4
BELLICUM PHARMACEUTICALS, INC
5 Jan 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
29 May 24 | ACAD Acadia Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 6,652 | 0.00 | 24,654 |
29 May 24 | ACAD Acadia Pharmaceuticals | RSU Common Stock | Grant | Acquire A | No | No | 0 | 9,387 | 0.00 | 9,387 |
29 May 24 | ACAD Acadia Pharmaceuticals | Director Stock Options Common Stock | Grant | Acquire A | No | No | 14.62 | 15,959 | 233.32 k | 15,959 |
29 May 24 | ACAD Acadia Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 6,652 | 0.00 | 0 |
2 Apr 24 | MDGL Madrigal Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 248.4508 | 200 | 49.69 k | 1,198 |
2 Apr 24 | MDGL Madrigal Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 247.0342 | 43 | 10.62 k | 1,398 |
2 Apr 24 | MDGL Madrigal Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 246.2958 | 557 | 137.19 k | 1,441 |
2 Apr 24 | MDGL Madrigal Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 244.8946 | 2,991 | 732.48 k | 1,998 |
2 Apr 24 | MDGL Madrigal Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 244.1927 | 6,279 | 1.53 mm | 4,989 |
2 Apr 24 | MDGL Madrigal Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 243.2559 | 842 | 204.82 k | 11,268 |